Back to resultsTopical Finasteride in the Treatment of Idiopathic Hirsutism
Primary Purpose
Idiopathic Hirsutism
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
topical finasteride
Sponsored by
About this trial
This is an interventional treatment trial for Idiopathic Hirsutism
Eligibility Criteria
Inclusion Criteria:
- Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation
- Normal serum prolactin
Exclusion Criteria:
- Pregnancy
- Simultaneous use of other drugs for the treatment of hirsutism
Sites / Locations
Outcomes
Primary Outcome Measures
the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication
Secondary Outcome Measures
the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication
Full Information
NCT ID
NCT00564252
First Posted
November 26, 2007
Last Updated
November 26, 2007
Sponsor
Iran University of Medical Sciences
Collaborators
Firuzgar hospital affiliated to Iran University of Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT00564252
Brief Title
Topical Finasteride in the Treatment of Idiopathic Hirsutism
Official Title
The Efficacy of Topical Finasteride in the Treatment of Idiopathic Hirsutism
Study Type
Interventional
2. Study Status
Record Verification Date
November 2007
Overall Recruitment Status
Completed
Study Start Date
February 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
October 2006 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Iran University of Medical Sciences
Collaborators
Firuzgar hospital affiliated to Iran University of Medical Sciences
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
the purpose of this study is to evaluate the efficacy of topical Finasteride in the treatment of idiopathic hirsutism
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Idiopathic Hirsutism
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Participant
Allocation
N/A
Enrollment
56 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
topical finasteride
Intervention Description
0.2%topical(cream)finasteride twice a day for six months
Primary Outcome Measure Information:
Title
the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication
Time Frame
6 months
Secondary Outcome Measure Information:
Title
the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication
Time Frame
6 months
10. Eligibility
Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation
Normal serum prolactin
Exclusion Criteria:
Pregnancy
Simultaneous use of other drugs for the treatment of hirsutism
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
iraj heydari, professor assistant
Organizational Affiliation
endocrine and metabolism centre of Iran University of Medical Sciences
Official's Role
Study Director
12. IPD Sharing Statement
Learn more about this trial
Topical Finasteride in the Treatment of Idiopathic Hirsutism
We'll reach out to this number within 24 hrs